SEC Form 4 · accession 0001209191-17-004563
INCYTE CORP · INCY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yao Wenqing
Officer — EVP, Head of Discovery Chem
Period of report
Jan 17, 2017
Accepted (ET)
Jan 19, 2017 · 4:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879169
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $113.64 | Jan 17, 2017 | A | 19,091 | A | — | Jan 16, 2027 | Common Stock | 19,091 | 19,091 | D |
| Non-Qualified Stock Option (right to buy)F2 | $113.64 | Jan 17, 2017 | A | 17,986 | A | — | Jan 16, 2027 | Common Stock | 17,986 | 17,986 | D |
| Incentive Stock Option (right to buy)F2 | $113.64 | Jan 17, 2017 | A | 879 | A | — | Jan 16, 2027 | Common Stock | 879 | 879 | D |
Explanation of responses
- F1Beginning January 17, 2017, options become exercisable in 37 installments, with the first 25.00% vesting on July 15, 2017 and the remainder vesting monthly over three years.
- F2Beginning January 17, 2017, options become exercisable in full on January 17, 2021.